Invesco Biotechnology & Genome ETF closed at $97.29 on Sep 28, up 0.03%, 1.5% below its 52-week closing high. Volume of 12.1K shares was 0.59× its 20-day average (below normal).
Split-adjusted performance: -1.3% over one month, +28.7% over six months, +43.4% over one year.
Short interest was 12.3K shares at the Sep 15 settlement, down 46.9% from the prior report (1.0 days to cover).
Does Invesco Biotechnology & Genome ETF pay a dividend?
Yes. The latest regular dividend was $0.0187 per share (ex-date Sep 21), an annualised yield of 0.08%.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology